Page last updated: 2024-12-04

1-butanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-Butanol: A Versatile Compound for Research

1-Butanol, also known as n-butanol, is a **primary alcohol** with the chemical formula **CH3(CH2)3OH**. It's a colorless, flammable liquid with a characteristic alcoholic odor. Its importance in research stems from its diverse applications and potential for various scientific investigations.

Here's a breakdown of 1-butanol's relevance:

**1. Chemical and Material Science:**

* **Solvent and Reagent:** 1-Butanol is a versatile solvent used in a variety of chemical reactions and processes, including the production of paints, varnishes, resins, and plastics.
* **Biofuel:** 1-Butanol is a promising biofuel candidate due to its high energy content, good compatibility with existing gasoline infrastructure, and low water solubility, making it an attractive alternative to ethanol.
* **Synthetic Chemistry:** 1-Butanol is a key intermediate in the production of various chemical compounds, including pharmaceuticals, pesticides, and fragrances.

**2. Biology and Biochemistry:**

* **Cell Culture:** 1-Butanol can be used as a solvent and a reagent in cell culture experiments, helping to understand cell function and behavior.
* **Enzymatic Studies:** It serves as a substrate for certain enzymes, allowing researchers to investigate enzyme kinetics and mechanisms.

**3. Environmental and Sustainability Research:**

* **Bio-based Production:** Researchers are actively exploring sustainable and bio-based methods to produce 1-butanol from renewable resources like biomass, leading to less reliance on fossil fuels.
* **Green Chemistry:** 1-Butanol's potential as a biofuel aligns with the principles of green chemistry, emphasizing the use of renewable resources and environmentally friendly production methods.

**4. Other Areas of Research:**

* **Food Science:** 1-Butanol is used in food processing as a flavoring agent and a solvent for food additives.
* **Pharmaceuticals:** It can be found in some pharmaceutical formulations as an excipient or solvent.
* **Material Science:** 1-Butanol plays a role in the synthesis of various polymers and materials, including biodegradable plastics.

**In conclusion,** 1-butanol is a versatile compound with a wide range of applications in various research fields. Its importance lies in its potential for developing sustainable technologies, understanding biological processes, and advancing chemical synthesis and material science.

1-Butanol: A four carbon linear hydrocarbon that has a hydroxy group at position 1. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

butan-1-ol : A primary alcohol that is butane in which a hydrogen of one of the methyl groups is substituted by a hydroxy group. It it produced in small amounts in humans by the gut microbes. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID263
CHEMBL ID14245
CHEBI ID28885
MeSH IDM0029707

Synonyms (170)

Synonym
BIDD:ER0611
chembl14245 ,
bdbm36173
CHEBI:28885 ,
n-butylalkohol
propyl carbinol
1-butyl alcohol
buoh
normal primary butyl alcohol
butyric or normal primary butyl alcohol
D03200
butyl alcohol (nf)
butyl alcohol
butyric alcohol
butylowy alkohol
butanolo
propylmethanol
n-butanolbutanolen
alcool butylique
nsc62782
ccs 203
butyl hydroxide
hemostyp
methylolpropane
nsc-62782
wln: q4
n-butan-1-ol
propylcarbinol
butyl alcohol (natural)
butanolen [dutch]
alcool butylique [french]
butanol [french]
hsdb 48
nsc 62782
ai3-00405
butylowy alkohol [polish]
ccris 4321
einecs 200-751-6
rcra waste no. u031
rcra waste number u031
fema no. 2178
butanol, 1-
fema number 2178
butanolo [italian]
1-butanol, anhydrous, 99.8%
inchi=1/c4h10o/c1-2-3-4-5/h5h,2-4h2,1h
1bo ,
NCGC00090961-01
NCGC00090961-02
1-butanol
n-butyl alcohol
1-hydroxybutane
butan-1-ol
n-butanol
C06142
71-36-3
BUTANOL ,
butyl alcohol, natural, >=99.5%, fcc, fg
1-butanol, analytical standard
1-butanol, for molecular biology, >=99%
butyl alcohol, >=99.9%, fcc
DB02145
alcohol, butyl
n butanol
alcohol, n-butyl
n butyl alcohol
1 butanol
butanols
1-butanol, spectrophotometric grade, 99.5%
BDBC6468-886D-4F6C-8746-734F2B63E6CE
B0228
B0704
B0944
AKOS000249218
BMSE000447
LMFA05000109
NCGC00090961-03
n-buoh
NCGC00258295-01
tox21_200741
tox21_111046
dtxcid701740
dtxsid1021740 ,
cas-71-36-3
unii-wb09ny83ya
wb09ny83ya ,
35296-72-1
n-butanol, acs, 99.4+%
butyl alcohol [nf]
ec 200-751-6
unii-8pj61p6ts3
8pj61p6ts3 ,
butanolen
1-butanol-4,4,4-d3
FT-0607555
FT-0623296
n-butyl alcohol [who-dd]
butyl alcohol [ii]
alcohol,butyl
butyl alcohol [fhfi]
butyl alcohol [hsdb]
butyl alcohol [fcc]
tributyl acetylcitrate impurity d [ep impurity]
butyl alcohol [mart.]
n-butyl alcohol [mi]
alcohol,butyl [vandf]
n-butyl alcohol [inci]
1-butanol [usp-rs]
STL264186
6167-45-9
vanadium tetrabutoxide
BP-30034
n-c4h9oh
1-n-butanol
n-butylalcohol
butyl-alcohol
1 -butanol
1- butanol
butylalcohol
normal butanol
butaneol
butanol-1
nbuoh
1-butylalcohol
32586-14-4
1-butanol-2,2,3,3,4,4,4-d7
mfcd00002964
64118-16-7
1-butanol, anhydrous
1-butanol, ultrapure, spectrophotometric grade
1-butanol, hplc grade
F0001-1830
1-butanol, 99%
1-butanol, for hplc
1-butanol, acs reagent, >=99.4%
1-butanol, saj first grade, >=99.0%
1-butanol, for hplc, 99.8%
1-butanol, united states pharmacopeia (usp) reference standard
1-butanol, jis special grade, >=99.0%
1-butanol, for hplc, >=99.7%
1-butanol, puriss. p.a., acs reagent, >=99.5% (gc)
1-butanol, 99.9%
1-butanol, puriss. p.a., acs reagent, reag. iso, reag. ph. eur., >=99.5% (gc)
1-butanol, for hplc, >=99.8% (gc)
1-butanol, anhydrous, zero2(tm), 99.8%
n-propyl carbinol
1-butanol, p.a., acs reagent, 99.4%
1-butanol, pharmaceutical secondary standard; certified reference material
1-butanol, lr, >=99%
1-butanol, acs reagent, reag. iso, reag. ph. eur., 99.5%
1-butanol, uv hplc spectroscopic, 99.5%
1-butanol, ar, >=99.5%
butyl alcohol, >=99.9%, fcc, fg
n-butanol, butan-1-ol, 1-butanol
1-butanol 500 microg/ml in methanol
n-butyl-1,1-d2 alcohol
n-butanol, hplc grade
1219794-84-9
n-butyl alcohol,(s)
Q16391
FT-0774976
1-butanol-3,3,4,4,4-d5
n-butyl--d6 alcohol
EN300-19305
butan-1-olate,vanadium(4+)
butyl alcohol (mart.)
butyl alcohol (ii)
1-butanol (butyl alcohol)
n-propylcarbinol
tributyl acetylcitrate impurity d (ep impurity)

Research Excerpts

Overview

1-Butanol (1-BD) is a promising fuel additive. It can be biosynthesized via reversed β-oxidation pathway in bacteria. 1-BD is an important industrial platform chemical and an advanced biofuel.

ExcerptReferenceRelevance
"1-Butanol (1-BD) is a promising fuel additive which can be biosynthesized via reversed β-oxidation pathway in bacteria. "( Metabolic Checkpoint Aldehyde Dehydrogenases Are Important for Diverting β-Oxidation into 1-Butanol Biosynthesis from Kitchen Waste Oil in Pseudomonas aeruginosa.
Ge, X; Li, Y; Liu, Z, 2021
)
2.29
"1-Butanol is an important industrial platform chemical and an advanced biofuel. "( Construction of CoA-dependent 1-butanol synthetic pathway functions under aerobic conditions in Escherichia coli.
Kataoka, N; Kato, J; Matsushita, K; Pongtharangkul, T; Tajima, T; Vangnai, AS; Yakushi, T, 2015
)
2.15
"1-Butanol, which is a substrate for PLD and inhibits PA formation, inhibited carbachol-induced cell proliferation and the underlying intracellular signaling, whereas its analog tert-butanol, which is a poor substrate for PLD, was much less effective."( Role of phospholipase D signaling in ethanol-induced inhibition of carbachol-stimulated DNA synthesis of 1321N1 astrocytoma cells.
Costa, LG; Guizzetti, M; Kim, Y; Thompson, BD; VanDeMark, K, 2004
)
1.04
"1-Butanol is a colourless organic solvent with a rancid sweet odour. "( Butanol ingestion in an airport hangar.
Brvar, M; Bunc, M; Mozina, H; Mozina, M; Pezdir, T, 2006
)
1.78
"1-Butanol is a large-volume, intermediate chemical with favorable physical and chemical properties for blending with or directly substituting for gasoline. "( Improving butanol fermentation to enter the advanced biofuel market.
Tracy, BP, 2012
)
1.82

Effects

1-Butanol has been utilized widely in industry and can be produced or transformed by microbes. High 1-butanol titer has been achieved in a transgenic Escherichia coli strain.

ExcerptReferenceRelevance
"High 1-butanol titer has been achieved in a transgenic Escherichia coli strain JCL299FT with a heterologous 1-butanol pathway by deleting competing pathways, balancing of cofactor and resolving free CoA imbalance. "( Metabolome analysis revealed the knockout of glyoxylate shunt as an effective strategy for improvement of 1-butanol production in transgenic Escherichia coli.
Fukusaki, E; Laviña, WA; Liao, JC; Nitta, K; Pontrelli, S; Putri, SP, 2019
)
1.24
"1-Butanol has been utilized widely in industry and can be produced or transformed by microbes. "( Untargeted metabolomics analysis revealed changes in the composition of glycerolipids and phospholipids in Bacillus subtilis under 1-butanol stress.
Mahipant, G; Sangvanich, P; Vangnai, AS; Vinayavekhin, N, 2015
)
2.06

Toxicity

1-butanol is developmental toxic only at maternal toxic doses. Only teratogenicity observed was a slight increase in skeletal malformations (primarily rudimentary cervical ribs), seen with the highest concentration.

ExcerptReferenceRelevance
" CHB is also a possible inducer of tissue glutathione in the liver and kidneys as well as in the pancreas, even at toxic doses."( Selective pancreato-toxicity in the rat induced by the naturally occurring plant nitrile 1-cyano-2-hydroxy-3-butene.
Fettman, MJ; Gould, DH; Wallig, MA, 1988
)
0.27
" Even at a maternally toxic dose, and in spite of a dose-dependent reduction in fetal weights for each isomer, the only teratogenicity observed was a slight increase in skeletal malformations (primarily rudimentary cervical ribs), seen with the highest concentration of 1-butanol."( Lack of selective developmental toxicity of three butanol isomers administered by inhalation to rats.
Brightwell, WS; Burg, JR; Goad, PT; Khan, A; Nelson, BK, 1989
)
0.46
" These results show that interaction of TBA+TCA does bring about alteration in biochemical parameters which may play a pivotal role in toxic responses on long-term exposure."( Administration of subtoxic doses of t-butyl alcohol and trichloroacetic acid to male Wistar rats to study the interactive toxicity.
Acharya, S; Krishnan, S; Mehta, K; Pereira, J; Rao, CV; Rodrigues, S, 1995
)
0.29
" Thus, in condition of combined exposure, the toxic effect of m-xylene was not added to the effect of n-butyl alcohol."( Toxic effects of subchronic combined exposure to n-butyl alcohol and m-xylene in rats.
Korsak, Z; Swiercz, R; Wiśniewska-Knypl, J, 1994
)
0.29
" Lifibrol was generally well tolerated in all dosage groups and no serious adverse events were reported."( Safety and efficacy of lifibrol upon four-week administration to patients with primary hypercholesterolaemia.
Augustin, J; Elsässer, R; Gertz, B; Heil, M; Schmidt, C; Schwandt, P; Seibel, K, 1994
)
0.29
"Recent confirmation that the toxic unsaturated aldehyde crotonaldehyde (CA) contributes to protein damage during lipid peroxidation confers interest on the molecular actions of this substance."( Oxidative bioactivation of crotyl alcohol to the toxic endogenous aldehyde crotonaldehyde: association of protein carbonylation with toxicity in mouse hepatocytes.
Burcham, PC; Dunlop, RA; Fontaine, FR; Petersen, DR, 2002
)
0.31
" The data demonstrate that 1-butanol is developmental toxic only at maternal toxic doses."( Evaluation of developmental toxicity of 1-butanol given to rats in drinking water throughout pregnancy.
Ema, M; Hara, H; Hirose, A; Kamata, E; Matsumoto, M, 2005
)
0.89
" n-Butyl Alcohol has been generally recognized as safe for use as a flavoring substance in food and appears on the 1982 Food and Drug Administration (FDA) list of inactive ingredients for approved prescription drug products."( Final report of the addendum to the safety assessment of n-butyl alcohol as used in cosmetics.
McLain, VC, 2008
)
0.35
" Food Allergy Herbal Formula-2 (FAHF-2) has profound therapeutic effects in a murine PNA model and is safe for food-allergic adults in clinical trials."( Efficacy, safety and immunological actions of butanol-extracted Food Allergy Herbal Formula-2 on peanut anaphylaxis.
Chen, Y; Goldfarb, J; Li, XM; Lopez-Exposito, I; Sampson, H; Song, Y; Srivastava, K; Yang, N; Zhan, J, 2011
)
0.37
" The Ames test results showed that CHB induced point mutation but not frameshift mutation, whereas the toxic effects of CBO made it difficult to reliably assess the mutagenic potential of CBO in the two strains."( Cytotoxicity, genotoxicity, and mutagenicity of 1-chloro-2-hydroxy-3-butene and 1-chloro-3-buten-2-one, two alternative metabolites of 1,3-butadiene.
An, J; Elfarra, AA; Liu, XJ; Yu, YX; Zeng, FM; Zhang, XY, 2013
)
0.39
" Our results help to elucidate the development mechanisms of RD-induced leukoderma and provide information for innovation of safe skin-whitening compounds."( 4-(4-Hydroxyphenyl)-2-butanol (rhododendrol)-induced melanocyte cytotoxicity is enhanced by UVB exposure through generation of oxidative stress.
Goto, N; Ito, S; Masaki, T; Nagai, H; Nishigori, C; Tsujimoto, M; Wakamatsu, K, 2018
)
0.48
" The plant extract had high antioxidant potential and completely prevented the toxic effect of PCP on the above of liver and serum parameters."( Hepatoprotective effects of the n-butanol extract from Perralderia coronopifolia Coss. against PCP-induced toxicity in Wistar albino rats.
Bekhouche, K; Benayache, F; Benayache, S; Boussaha, S; Demirtas, I; Kout, M; Ozen, T; Yildirim, K; Zama, D, 2019
)
0.51
" In this study, toxic effects of n-butanol's different concentrations (10, 50, 250, 500, 750, 1,000, and 1,250 mg/L) in Zebrafish Danio rerio embryos and larvae were investigated."( Teratogenic and Neurotoxic Effects of n-Butanol on Zebrafish Development.
Alak, G; Atamanalp, M; Çomaklı, S; Köktürk, M; Özkaraca, M, 2021
)
0.62
"Blends of biodiesel and high-carbon alcohols have the potential to increase the rate of biofuel use in diesel engines, while reducing harmful and toxic compounds such as polycyclic aromatic hydrocarbons (PAHs)."( Fuel effects on PAH formation, toxicity and regulated pollutants: Detailed comparison of biodiesel blends with propanol, butanol and pentanol.
Donaldson, B; Vigil, FM; Yilmaz, N, 2022
)
0.72
"Cadmium is an environmentally toxic metal that has deleterious effects on both animals and humans due to its accumulation in different body tissues."( Nephroprotective effect of Physalis peruviana L. calyx extract and its butanolic fraction against cadmium chloride toxicity in rats and molecular docking of isolated compounds.
Aboelyazed, AM; El-Sayed, EK; Ibrahim, HA; Korany, EM; Soliman, HSM, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
" to dogs, both W-2719 and W-2718 appeared in plasma but each had a very short half-life of about 10 min."( Metabolism and pharmacokinetics of 4-(p-chlorophenylthio)butanol (W-2719) in the rat and dog.
Ballard, FH; Edelson, J; Kucharczyk, N; Ludwig, BJ; Myers, G; Schuster, E; Shahinian, S; Sofia, RD; Yang, J, 1979
)
0.26
"A pharmacokinetic model is presented to describe the biotransformation of 2-butanol (2-OL) and its metabolites (2-butanone, 3-hydroxy-2-butanone, and 2, 3-butanediol) using in vivo experimental blood concentration."( Pharmacokinetics of 2-butanol and its metabolites in the rat.
Dietz, FK; Himmelstein, KJ; Rodriguez-Giaxola, M; Stella, VJ; Traiger, GJ, 1981
)
0.26
" Based on the pharmacokinetic data in 13 subjects the radiation doses to single organs were calculated according to MIRD pamphlet No."( Pharmacokinetics and radiation dose of oxygen-15 labelled butanol in rCBF studies in humans.
Herzog, H; Kleinschmidt, A; Müller-Gärtner, HW; Nebeling, B; Schlaug, G; Seitz, RJ; Stöcklin, G; Tellmann, L, 1994
)
0.29
" The objective of this study was to develop a physiologically based pharmacokinetic (PBPK) model for MTBE and TBA in rats that will form the basis for a human model."( Development of physiologically based pharmacokinetic model for methyl tertiary-butyl ether and tertiary-butanol in male Fisher-344 rats.
Borghoff, SJ; Medinsky, MA; Murphy, JE, 1996
)
0.29
"The metabolic series approach for risk assessment uses a dosimetry-based analysis to develop toxicity information for a group of metabolically linked compounds using pharmacokinetic (PK) data for each compound and toxicity data for the parent compound."( Derivation of a human equivalent concentration for n-butanol using a physiologically based pharmacokinetic model for n-butyl acetate and metabolites n-butanol and n-butyric acid.
Barton, HA; Clewell, HJ; Corley, RA; Deisinger, PJ; English, JC; Faber, WD; Poet, TS; Teeguarden, JG, 2005
)
0.33
" The method was successfully applied to a pharmacokinetic study in rats after an intragastric administration of echinacoside (100 mg/kg)."( A sensitive and specific liquid chromatography/tandem mass spectrometry method for determination of echinacoside and its pharmacokinetic application in rats.
Dai, L; Hao, H; Jiang, Y; Tu, P; Wang, G; Wang, Q; Wang, Y; Yang, H; Zhang, Y; Zheng, C, 2009
)
0.35
" To facilitate dose scaling between species, we developed a novel liquid chromatography/tandem mass spectrometry (LC-MS/MS) for the preclinical pharmacokinetic characterization of OTP in monkeys."( Development of an LC-MS/MS assay to determine plasma pharmacokinetics of the radioprotectant octadecenyl thiophosphate (OTP) in monkeys.
Gududuru, V; He, H; Kosanam, H; Ma, F; Miller, DD; Ramagiri, S; Tigyi, GJ; Van Rompay, K; Yates, CR, 2010
)
0.36
" The method was found to be suitable for the quantification of atenolol in a pharmacokinetic study after a single oral administration of 100 mg atenolol to 18 healthy subjects."( Determination of atenolol in human plasma by HPLC with fluorescence detection: validation and application in a pharmacokinetic study.
Niopas, I; Spanakis, M, 2013
)
0.39
" In this study, we examined the pharmacokinetic profiles of Compound D in male Wistar rats."( Pharmacokinetics of Compound D, the Major Bioactive Component of Zingiber cassumunar, in Rats.
Anukunwithaya, T; Bangphumi, K; Dechatiwongse Na Ayudhya, T; Hunsakunachai, N; Inthachart, T; Jiratchariyakul, W; Khemawoot, P; Koontongkaew, S; Ongpipattanakul, B; Poachanukoon, O; Soawakontha, R, 2016
)
0.43
" Compounds 3α-hydroxy-7,12-dioxo-5β-cholanoic and 12α-hydroxy-3,7-dioxo-5β-cholanoic acid might be the most suitable candidates for further development studies (satisfactory pharmacokinetic properties and lowest haemolytic potential) followed by 3α-hydroxy-12-oxo-5β-cholanoic acid and 3α-hydroxy-7-oxo-5β-cholanoic acid (slightly higher haemolytic potential, but better ligand properties)."( Retention data of bile acids and their oxo derivatives in characterization of pharmacokinetic properties and in silico ADME modeling.
Borčić, V; Kon, SG; Mikov, M; Trifunović, J; Vukmirović, S, 2016
)
0.43

Compound-Compound Interactions

ExcerptReferenceRelevance
"In the present work, a synergistic system of pulsed corona discharge combined with TiO(2) photocatalysis has been developed to investigate the degradation rate of phenol solutions by varying experimental conditions of gas bubbling varieties (air, O(2), and Ar), solution pH values, and radical scavenger additives."( Formation of hydrogen peroxide and degradation of phenol in synergistic system of pulsed corona discharge combined with TiO2 photocatalysis.
Li, G; Li, J; Quan, X; Wang, F; Wang, H; Wu, Y, 2007
)
0.34
" aeruginosa PAO1 biofilms, two-dimensional gel electrophoresis (2-DE) in combination with mass spectrometry-based protein identification were used."( Analysis of Pseudomonas aeruginosa PAO1 Biofilm Protein Profile After Exposure to n-Butanolic Cyclamen coum Extract Alone and in Combination with Ciprofloxacin.
Abdi-Ali, A; Akbari Noghabi, K; Shafiei, M; Shahbani Zahiri, H; Shahcheraghi, F; Vali, H, 2017
)
0.46
"To investigate the mechanism of n-butanol extract of Pulsatilla decoction (BAEB) against murine ulcerative colitis (UC) model induced by DSS combined with Candida albicans (CA) colonization, mice were randomly divided into normal control group, DSS group, DSS+CA group, BAEB high, medium and low dose group, and positive drug Mesalazine group."( [Therapeutic potential of n-butanol extract of Pulsatilla decoction in a murine model of ulcerative colitis induced by DSS combined with Candida albicans colonization].
Duan, QJ; Shao, J; Tian, G; Wang, CZ; Wang, TM; Wang, XM; Wu, DQ, 2018
)
0.48
"A solid-phase extraction method combined with deep eutectic solvent-based dispersive liquid-liquid microextraction has been developed for the extraction of three antibiotics in honey samples prior to their determination by ion mobility spectrometry."( Preparation of multiwall carbon nanotube/urea-formaldehyde nanocomposite as a new sorbent in solid-phase extraction and its combination with deep eutectic solvent-based dispersive liquid-liquid microextraction for extraction of antibiotic residues in hone
Afshar Mogaddam, MR; Javadi, A; Mirzaei, H; Nemati, M; Shahi, M, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
" Butanol reduced the rate of absorption of sulfapyridine but did not significantly affect the absorption rates of prednisolone or salicylic acid."( Effects of normal alcohols on intestinal absorption of salicylic acid, sulfapyridine, and prednisolone in rats.
Hayton, WL, 1975
)
0.25
"0 M, glycerin and propylene glycol increase significantly the intestinal absorption rate of theophylline from the small intestine of anesthetized rats."( Effect of various alcohols on intestinal net water flux and theophylline absorption in rats.
Houston, JB; Levy, G, 1975
)
0.25
" Assay development, validation, and application of the method to a bioavailability study of the racemate and enantiomers of lifibrol in dogs are described."( Chiral assay methods for lifibrol and metabolites in plasma and the observation of unidirectional chiral inversion following administration of the enantiomers to dogs.
Hsu, CY; Walters, RR, 1994
)
0.29
"The feasibility of a mild-solvent extraction procedure to predict the bioavailability of individual polycyclic aromatic hydrocarbons (PAHs) in soil was assessed."( Butanol extraction to predict bioavailability of PAHs in soil.
Alexander, M; Liste, HH, 2002
)
0.31
" The respiratory bioavailability of n-butyl acetate (100% of alveolar ventilation) and n-butanol (50% of alveolar ventilation) was estimated from closed chamber inhalation studies and measured ventilation rates."( Derivation of a human equivalent concentration for n-butanol using a physiologically based pharmacokinetic model for n-butyl acetate and metabolites n-butanol and n-butyric acid.
Barton, HA; Clewell, HJ; Corley, RA; Deisinger, PJ; English, JC; Faber, WD; Poet, TS; Teeguarden, JG, 2005
)
0.33
" These results suggest that it may be difficult to develop a chemical method that is capable of mimicking biological uptake, and thus estimating the bioavailability of PAHs."( Comparison of techniques for estimating PAH bioavailability: uptake in Eisenia fetida, passive samplers and leaching using various solvents and additives.
Andersson, PL; Bergknut, M; Haglund, P; Lundstedt, S; Sehlin, E; Tysklind, M, 2007
)
0.34
" Over the last decade regulators have directed concerted effort towards rationalization of risk-based contaminated land policies recognizing bioavailability and bioaccessibility as concepts to be incorporated into risk assessments."( Beyond contaminated land assessment: on costs and benefits of bioaccessibility prediction.
Latawiec, AE; Reid, BJ, 2009
)
0.35
" dPAHs have a similar fate to their respective undeuterated analogues, so chemical methods that give good indications of bioavailability should extract the fresh more readily available dPAHs and historic more recalcitrant PAHs in similar proportions to those in which they are accumulated in the tissues of test organisms."( Using deuterated PAH amendments to validate chemical extraction methods to predict PAH bioavailability in soils.
Collins, CD; Gomez-Eyles, JL; Hodson, ME, 2011
)
0.37
" Three chemical extractions as butanol, HPCD and Tenax extractions and earthworm accumulation were used to assess the changes of the bioavailability of CBs in soil."( [Influence and assessment of biochar on the bioavailability of chlorobenzenes in soil].
Bian, YR; Gu, CG; Jiang, X; Song, Y; Wang, F; Xie, ZB; Yang, XL, 2012
)
0.38
"n-butanol and hydroxypropyl-beta-cyclodextrin (HPCD) were used to extract polyclic aromatic hydrocarbons from 9 aged agricultural fields and to assess the PAHs bioavailability to earthworm (Eisenia fetida)."( [Mild solvent extraction technique for the evaluation of PAHs bioavailability].
Jiang, X; Lü, ZY; Wang, F; Yang, XL; Zhang, YP, 2011
)
0.37
" The sorption, dissipation, and bioavailability of chlorobenzenes (CBs) in soil were investigated."( Immobilization of chlorobenzenes in soil using wheat straw biochar.
Gu, C; Jiang, X; Kengara, FO; Song, Y; Wang, F; Yang, X, 2013
)
0.39
" Moreover, bioavailability and differences in substrate consumption and total n-butanol production with respect to solvent-free fermentations were quantified for each biocompatible solvent."( Solvent screening methodology for in situ ABE extractive fermentation.
González-Peñas, H; Lema, JM; Lu-Chau, TA; Moreira, MT, 2014
)
0.4
"56), which indicated that ASE extraction techniques could not predict PAHs bioavailability to earthworms because it overestimated the risk of PAHs."( [Aging Law of PAHs in Contaminated Soil and Their Enrichment in Earthworms Characterized by Chemical Extraction Techniques].
Bian, YR; Gu, CG; Jiang, X; Li, J; Liu, ZT; Wang, DZ; Yang, XL; Zhang, YN, 2015
)
0.42
"The effective permeability coefficient is of theoretical and practical importance in evaluation of the bioavailability of drug candidates."( Establishment of quantitative retention-activity model by optimized microemulsion liquid chromatography.
Gao, C; Gao, H; Li, L; Li, N; Li, Y; Wang, L; Xu, L, 2016
)
0.43
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" Aiming at predicting PCBs risk in actual soil ecosystem, this study was conducted by chemical and biological methods to assess the bioavailability of PCBs in spiked soil, and in field-contaminated soils before or after remediation."( Alternative Evaluation to Earthworm Toxicity Test in Polychlorinated Biphenyls Spiked and Remediated Soils.
Shen, C; Tang, X; Wan, J; Ye, Z; Yu, C; Zhang, C, 2020
)
0.56
", Tenax, hydroxypropyl[β]cyclodextrin (HPCD), n-butanol and low-molecular-weight-organic-acids (LMWOA), for predicting the bioavailability and phytotoxicity of soil phthalic acid esters to the green vegetable Shanghaiqing (SHQ)."( Comparison of Different Chemical Extraction Methods for Predicting the Bioavailability and Phytotoxicity of Soil PAEs to Green Vegetables (Brassica Rapa Var. Chinensis).
Chen, X; Cheng, J; Tian, L; Wan, Q; Yu, X, 2022
)
0.72
"Vascular dysfunction: develops progressively with ageing; increases the risk of cardiovascular diseases (CVD); and is characterized by endothelial dysfunction and arterial stiffening, which are primarily mediated by superoxide-driven oxidative stress and consequently reduced nitric oxide (NO) bioavailability and arterial structural changes."( Initiation of 3,3-dimethyl-1-butanol at midlife prevents endothelial dysfunction and attenuates in vivo aortic stiffening with ageing in mice.
Brunt, VE; Casso, AG; Clayton, ZS; Davy, KP; Gioscia-Ryan, RA; Greenberg, NT; Hutton, DA; Neilson, AP; Seals, DR; VanDongen, NS; Ziemba, BP, 2022
)
1.02

Dosage Studied

ExcerptRelevanceReference
" No significant effect of prolonged dosing of 14C-W-2719 to dogs was observed on plasma 14C levels, peak time, 14C half-life or excretion and composition patterns."( Metabolism and pharmacokinetics of 4-(p-chlorophenylthio)butanol (W-2719) in the rat and dog.
Ballard, FH; Edelson, J; Kucharczyk, N; Ludwig, BJ; Myers, G; Schuster, E; Shahinian, S; Sofia, RD; Yang, J, 1979
)
0.26
" A dose-response relationship was always obtained, the threshold dose being 25--100 mg/kg."( Pharmacology of dihydroxy-dibutylether, a specific choleretic drug.
Fregnan, GB; Porta, R, 1976
)
0.26
" Ninety-day toxicity studies were conducted in B6C3F1 mice and Fischer 344 (F344) rats of both sexes using dosed water."( Subchronic toxicity studies of t-butyl alcohol in rats and mice.
Collins, JJ; Farnell, DR; Giles, HD; Lindamood, C; Maronpot, RR; Prejean, JD; Takahashi, K, 1992
)
0.28
" Cross-tolerance was shown by shifts in dose-response curves for the LRR induced by n-propanol and t-butanol."( Effects of chronic treatment with ethanol on the development of cross-tolerance to other alcohols and pentobarbital.
Kalant, H; Khanna, JM; Lê, AD, 1992
)
0.28
" A 135-197% increase in acetanilide hydroxylase activity was found in rats sacrificed 12-40 h after dosing with 2-butanol or 2-butanone."( Effect of 2-butanol and 2-butanone on rat hepatic ultrastructure and drug metabolizing enzyme activity.
Bruckner, JV; Cooke, PH; Dietz, FK; Jiang, WD; Traiger, GJ, 1989
)
0.28
" Of potential physiological significance was finding that ethanol inhibited import in a dose-response fashion; 50% inhibition occurred at 75 mM, a concentration achievable during the ingestion of alcohol."( Liver mitochondrial aldehyde dehydrogenase: in vitro expression, in vitro import, and effect of alcohols on import.
Farrés, J; Wang, TT; Weiner, H, 1989
)
0.28
" This enhancement was dependent on dosage of crude n-butyl alcohol extracts and these TcHMC-1 cells were still cytotoxic specifically for HMC-1-8 targets, but not for other allogenic tumor lines including K562."( Characterization of n-butyl alcohol solubilized, breast tumor specific antigens recognized by a human autologous cytotoxic T-cell clone.
Asaishi, K; Kukuchi, K; Okazaki, M; Okubo, M; Sato, N; Sato, T; Takahashi, N; Takahashi, S; Torigoe, T; Yagihashi, A, 1988
)
0.27
" Time course experiments and dose-response experiments indicated that an increase in the microsomal oxidation of alcohols could be observed 24 hr after a single treatment with 200 mg/kg body weight of either pyrazole or 4-methylpyrazole, and after 2 or 3 days of treatment with 50 mg/kg of either of these compounds."( Interaction of pyrazole and 4-methylpyrazole with hepatic microsomes: effect on cytochrome P-450 content, microsomal oxidation of alcohols, and binding spectra.
Cederbaum, AI; Feierman, DE,
)
0.13
" In order to evaluate the interactive toxicity of t-butyl alcohol (TBA) with TCA, young male Wistar rats were dosed through water at a dose level of TBA (0."( Administration of subtoxic doses of t-butyl alcohol and trichloroacetic acid to male Wistar rats to study the interactive toxicity.
Acharya, S; Krishnan, S; Mehta, K; Pereira, J; Rao, CV; Rodrigues, S, 1995
)
0.29
" Replicative DNA synthesis, as measured by immunohistochemical staining for proliferating cell nuclear antigen, was increased in proximal tubules of rats dosed with 2% t-butyl alcohol."( Retrospective study of possible alpha-2 mu-globulin nephropathy and associated cell proliferation in male Fischer 344 rats dosed with t-butyl alcohol.
Lindamood, C; Maronpot, RR; Takahashi, K, 1993
)
0.29
" The first study consisted of active dosing of 4 weeks, and the second study had 12 weeks of active dosing."( Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group.
Francom, SF; Hughes, GS; Jungbluth, GL; Locker, PK, 1995
)
0.29
" With the present study design, a decrease in triglycerides (-28%) was significant in the highest dosage group only."( Safety and efficacy of lifibrol upon four-week administration to patients with primary hypercholesterolaemia.
Augustin, J; Elsässer, R; Gertz, B; Heil, M; Schmidt, C; Schwandt, P; Seibel, K, 1994
)
0.29
" For liquid permeation experiments, neat chemicals were dosed directly on the surface of the skin."( An in vitro comparison of the permeation of chemicals in vapor and liquid phase through pig skin.
Jacobs, RR; Phanprasit, W, 1993
)
0.29
" Oral dosing of 50mg of butanol extract in eight doses over 3 days reduced (P<0."( Studies on the use of Yucca schidigera to control giardiosis.
Annett, CB; Cheeke, PR; Cockwill, CL; McAllister, TA; Olson, ME; Wang, Y, 2001
)
0.31
" Unfortunately, their large-scale use is limited by the incorporation methods available, especially when sterile dosage forms are sought."( A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers.
Dufresne, MH; Fournier, E; Leroux, JC; Ranger, M; Smith, DC, 2004
)
0.32
" The dose-response curve was typical of a quorum-sensing type mechanism."( PI factor, a novel type quorum-sensing inducer elicits pimaricin production in Streptomyces natalensis.
Aparicio, JF; Colinas, A; Martín, JF; Recio, E; Rumbero, A, 2004
)
0.32
"A transdermal dosage form of trazodone hydrochloride (TZN) may be useful in the treatment of moderate to severe depression in schizophrenic patients by providing prolonged duration of action."( Effect of penetration enhancers on skin permeation of trazodone hydrochloride from matrix type transdermal formulation through mouse and human cadaver epidermis.
Bhattacharya, A; Das, MK; Ghosal, SK,
)
0.13
" Brandis is an important component of commonly dispensed traditional dosage forms."( Pharmacological basis for use of Pistacia integerrima leaves in hyperuricemia and gout.
Ahmad, NS; Farman, M; Hasan, A; Mian, KB; Najmi, MH, 2008
)
0.35
"To assess OERPs in patients with olfactory impairment and in healthy controls to investigate possible dose-response effects of odor concentration on OERP parameters in these groups, thereby exploring possibilities and limitations regarding the clinical utility of the OERP method."( Event-related potentials in patients with olfactory loss.
Bende, M; Brämerson, A; Larsson, C; Millqvist, E; Olofsson, JK; Ydse, B, 2008
)
0.35
" We investigated various butanol production systems with high density of living cells of Clostridium saccharoperbutylacetonicum N1-4 supplemented with methyl viologen (MV) as an electron carrier and nutrient dosing for activity regeneration."( Development of high-speed and highly efficient butanol production systems from butyric acid with high density of living cells of Clostridium saccharoperbutylacetonicum.
Baba, S; Shinto, H; Sonomoto, K; Tashiro, Y, 2012
)
0.38
" The EAG response of male antennae to a 50:50 ratio (racemic mixture) showed a similar dose-response curve to that of (R)-2-butanol."( Age-dependent changes in the ratio of (R)- and (S)-2-butanol released by virgin females of Dasylepida ishigakiensis (Coleoptera: Scarabaeidae).
Arakaki, N; Fujiwara-Tsujii, N; Mochizuki, F; Wakamura, S; Yasui, H, 2012
)
0.38
"15 mol x L(-1) of KCl, dosage of n-butanol 2%."( [Study on the backward extraction of cellulase in rhamnolipid reverse micelles].
Cui, KL; Huang, HJ; Peng, X; Peng, ZY; Yuan, XZ; Zeng, GM; Zhao, YG, 2014
)
0.4
" Blood, tissues, urine, and feces were collected from 0 to 48 h after dosing and the level of Compound D was determined by liquid chromatography-tandem mass spectrometry."( Pharmacokinetics of Compound D, the Major Bioactive Component of Zingiber cassumunar, in Rats.
Anukunwithaya, T; Bangphumi, K; Dechatiwongse Na Ayudhya, T; Hunsakunachai, N; Inthachart, T; Jiratchariyakul, W; Khemawoot, P; Koontongkaew, S; Ongpipattanakul, B; Poachanukoon, O; Soawakontha, R, 2016
)
0.43
"67 g/(L h) at 10 FPU/g cellulase dosage and 15% (w/w) solids content, an increase of 49."( Periodic peristalsis increasing acetone-butanol-ethanol productivity during simultaneous saccharification and fermentation of steam-exploded corn straw.
Chen, H; Li, J; Wang, L, 2016
)
0.43
"A fast and selective capillary electrophoresis method has been developed for the simultaneous determination of the antihypertensive drugs captopril and hydrochlorothiazide and their related impurities in a combined dosage form."( Cyclodextrin- and solvent-modified micellar electrokinetic chromatography for the determination of captopril, hydrochlorothiazide and their impurities: A Quality by Design approach.
Brusotti, G; Caprini, C; Del Bubba, M; Furlanetto, S; Innocenti, M; Orlandini, S; Pasquini, B, 2016
)
0.43
" Full-cell catalysis temperature and the cell dosage rate on oleate production were evaluated and optimized in the esterification process."( Simultaneous acetone-butanol-ethanol fermentation, gas stripping, and full-cell-catalyzed esterification for effective production of butyl oleate.
Cai, D; Cai, J; Chen, B; Chen, C; Chen, H; Qin, P; Sun, G; Tan, T; Zhen, Y, 2018
)
0.48
"05, indicating a non-monotonic dose-response profile."( Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line.
Agil, M; Hasanah, M; Laswati, H; Ma'arif, B; Mirza, DM, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Mineral Fusion Nail Lacquer Base Coat -- 0.33 fl ozMineral FusionBeauty & Personal Caren-butyl alcohol, trimethyl pentanyl diisobutyrate, butyl acetate, triphenyl phosphate2024-11-29 10:47:42

Roles (3)

RoleDescription
protic solventA polar solvent that is capable of acting as a hydron (proton) donor.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
alkyl alcoholAn aliphatic alcohol in which the aliphatic alkane chain is substituted by a hydroxy group at unspecified position.
primary alcoholA primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.
short-chain primary fatty alcohol
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (11)

PathwayProteinsCompounds
volatile esters biosynthesis (during fruit ripening)018
superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation1855
pyruvate fermentation to acetone529
superpathway of Clostridium acetobutylicum solventogenic fermentation1444
butanol and isobutanol biosynthesis (engineered)1320
glycerol degradation to butanol1035
pyruvate fermentation to butanol II (engineered)615
1-butanol autotrophic biosynthesis (engineered)4938
pyruvate fermentation to butanol I1125
butachlor degradation013
butane degradation816
volatile esters biosynthesis (during fruit ripening)220

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.31620.003245.467312,589.2998AID2517
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency25.11890.000214.376460.0339AID588532
farnesoid X nuclear receptorHomo sapiens (human)Potency48.79250.375827.485161.6524AID743220
estrogen nuclear receptor alphaHomo sapiens (human)Potency48.36030.000229.305416,493.5996AID1259244
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency48.36030.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency0.66820.002319.595674.0614AID651631
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency48.36030.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Choline O-acetyltransferase Rattus norvegicus (Norway rat)Ki47,000.00000.00020.00130.0030AID30246
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (20)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID1594652Substrate activity at Geobacillus stearothermophilus DSM 2334 ADH expressed in Escherichia coli BL21 (DE3) assessed as Km in 50 mM HEPES buffer at pH 7.5 at 23 degC by MTT dye based Lineweaver-Burk plot analysis2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Characterization of the substrate scope of an alcohol dehydrogenase commonly used as methanol dehydrogenase.
AID212400Toxicity determined using Tadpole Narcosis Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID1134606Et2O-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID159270Toxicity determined using Microtox Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID1134605Oil-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID101345Toxicity determined using Golden Orfe Fish Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID23252Partition coefficient (logP) (benzene)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1594653Substrate activity at Geobacillus stearothermophilus DSM 2334 ADH expressed in Escherichia coli BL21 (DE3) assessed as Kcat/Km ratio in 50 mM HEPES buffer at pH 7.5 at 23 degC by MTT dye based Lineweaver-Burk plot analysis2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Characterization of the substrate scope of an alcohol dehydrogenase commonly used as methanol dehydrogenase.
AID1102450Fungitoxicity against Colletotrichum gloeosporioides assessed as mycelial growth inhibition by poisoned food technique2003Journal of agricultural and food chemistry, Aug-27, Volume: 51, Issue:18
Quantitative structure-fungitoxicity relationships of some monohydric alcohols.
AID23255Partition coefficient (logP) (ether)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID23254Partition coefficient (logP) (chloroform)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1582364Lipophilicity, logP of the compound by 19F NMR-based method2020Journal of medicinal chemistry, 02-13, Volume: 63, Issue:3
Systematic Investigation of Lipophilicity Modulation by Aliphatic Fluorination Motifs.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID1594651Substrate activity at Geobacillus stearothermophilus DSM 2334 ADH expressed in Escherichia coli BL21 (DE3) assessed as Kcat in 50 mM HEPES buffer at pH 7.5 at 23 degC by MTT dye based Lineweaver-Burk plot analysis2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Characterization of the substrate scope of an alcohol dehydrogenase commonly used as methanol dehydrogenase.
AID23251Partition coefficient (logP)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID167125Eye irritation potential accessed using Draize in vivo rabbit eye irritation test2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
AID23253Partition coefficient (logP) (carbon tetrachloride)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID30246Compound was evaluated for reversible inhibition of hydrolysis acetylcholine by acetylcholinesterase and represented as KI(com)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
Effects of charge, volume, and surface on binding of inhibitor and substrate moieties to acetylcholinesterase.
AID30253Compound was evaluated for reversible inhibition of hydrolysis acetylcholine by acetylcholinesterase and represented as Km(app) apparent binding constant1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
Effects of charge, volume, and surface on binding of inhibitor and substrate moieties to acetylcholinesterase.
AID23256Partition coefficient (logP) (hexane)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID168703Inhibition of Rana pipiens muscle activity.1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4,267)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901076 (25.22)18.7374
1990's399 (9.35)18.2507
2000's778 (18.23)29.6817
2010's1621 (37.99)24.3611
2020's393 (9.21)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 81.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index81.58 (24.57)
Research Supply Index8.41 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index148.98 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (81.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials44 (0.99%)5.53%
Reviews175 (3.95%)6.00%
Case Studies11 (0.25%)4.05%
Observational2 (0.05%)0.25%
Other4,202 (94.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]